Lucy Fletcher - Concepedia

Author

Lucy Fletcher

Also Known As

D Fleming-Brown, Fletcher, Lucy, L Fletcher, L. Fletcher, Laura Fletcher, Lucy Fletcher, Rejive Dayanandan, Riti Desai, W. Brudlo

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Nottingham University Hospitals NHS Trust King's College London University of Bristol University of Nottingham

About

Lucy Fletcher is an author at University of Oxford specializing in medicine, covid-19, and hospital medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	937
2	Hospital Medicine	1	1	555
3	Antibiotics	1	1	555
4	Clinical Microbiology	1	1	555
5	Clinical Trials	1	1	382

Lucy Fletcher

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys Marian Knight, Sarah Stewart‐Brown, Lucy Fletcher Journal of Public Health	2001	150
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Making trials part of good clinical care: lessons from the RECOVERY trial Guilherme Pessoa-Amorim, Mark Campbell, Lucy Fletcher, Future Healthcare Journal	2021	65
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31

Page 1